MINIMS TETRACAINE HYDROCHLORIDE Single-use, sterile eye drops (2015)
Βιβλιογραφική αναφορά
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Περιεχόμενα
Name of the medicinal product
Minims Tetracaine Hydrochloride 0.5% w/v Eye Drops, Solution.
Qualitative and quantitative composition
Single-use, clear, colourless, sterile eye drops containing tetracaine hydrochloride Ph.Eur. 0.5% w/v solution.
Pharmaceutical form
Single-use, sterile eye drops.
Therapeutic indications
Ocular anaesthetic for topical instillation into the conjunctival sac.
Posology and method of administration
Adults and children One drop or as required. Each Minims unit should be discarded after use.
Contraindications
Not to be used in patients with a known hypersensitivity to the product. Tetracaine is hydrolysed in the body to p-amino-benzoic acid and should not therefore be used in patients being treated with sulphonamides. ...
Special warnings and precautions for use
The anaesthetised eye should be protected from dust and bacterial contamination. The cornea may be damaged by prolonged application of anaesthetic eye drops. Systemic absorption may be reduced by compressing ...
Interaction with other medicinal products and other forms of interaction
Tetracaine should not be used in patients being treated with sulphonamides (see 4.3 above).
Pregnancy and lactation
Safety for use in pregnancy and lactation has not been established, therefore, use only when considered essential by the physician.
Effects on ability to drive and use machines
May cause transient blurring of vision on instillation. Warn patients not to drive or operate hazardous machinery unless vision is clear.
Undesirable effects
Tetracaine may give rise to dermatitis in hypersensitive patients. On instillation an initial burning sensation may be experienced. This may last for up to 30 seconds. Corneal disorders such as superficial ...
Overdose
Not expected.
Pharmacodynamic properties
Tetracaine hydrochloride is used as a local anaesthetic which acts by reversibly blocking the propagation and conduction of nerve impulses along nerve axons. Tetracaine stabilises the nerve membrane, preventing ...
Pharmacokinetic properties
Tetracaine is a weak base (pK<sub>a</sub> 8.5), therefore, significant changes in the rate of ionised lipid soluble drug uptake may occur with changes in the acid base balance. In vitro studies have shown ...
Preclinical safety data
No adverse safety issues were detected during the development of this formulation. The active ingredient is well established in clinical ophthalmology.
List of excipients
Hydrochloric acid Purified water
Incompatibilities
None known.
Shelf life
Shelf life Unopened: 18 Months.
Special precautions for storage
Do not store above 25°C. Store in the original package in order to protect from light. Do not freeze.
Nature and contents of container
A sealed conical shaped polypropylene container fitted with a twist and pull off cap. Overwrapped in an individual polypropylene/paper pouch. Each container holds approximately 0.5ml of solution.
Special precautions for disposal and other handling
Each Minims unit should be discarded after use.
Marketing authorization holder
Bausch & Lomb UK Limited, Bausch & Lomb House, 106 London Road, Kingston-Upon-Thames, Surrey, UK, KT2 6TN
Marketing authorization number(s)
PL 03468/0082
Date of first authorization / renewal of the authorization
Date of first authorisation: 1.5.87
Date of revision of the text
January 2015
Πηγαίο έγγραφο
Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:
